{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:30:44Z","timestamp":1790508644930,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":452,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["2019R1F1A1054111"],"award-info":[{"award-number":["2019R1F1A1054111"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-2018R1A2B6001104"],"award-info":[{"award-number":["NRF-2018R1A2B6001104"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004567","name":"Ministry of Education, Government of the People's Republic of Bangladesh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1093\/advances\/nmaa080","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T07:21:26Z","timestamp":1591946486000},"page":"1686-1695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain"],"prefix":"10.1016","volume":"11","author":[{"given":"Young-Kook","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9165-8507","authenticated-orcid":false,"given":"Juhyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1093\/advances\/nmaa080_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0271678X15606723","article-title":"Cerebral small vessel disease: capillary pathways to stroke and cognitive decline","volume":"36","author":"Ostergaard","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1093\/advances\/nmaa080_bib2","doi-asserted-by":"crossref","first-page":"b75","DOI":"10.1136\/bmj.b75","article-title":"Dementia","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"issue":"25","key":"10.1093\/advances\/nmaa080_bib3","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","article-title":"Vascular cognitive impairment and dementia: JACC Scientific Expert Panel","volume":"73","author":"Iadecola","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1750-3639.2012.00575.x","article-title":"Pathology of lacunar ischemic stroke in humans\u2014a systematic review","volume":"22","author":"Bailey","year":"2012","journal-title":"Brain Pathol"},{"issue":"6","key":"10.1093\/advances\/nmaa080_bib6","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1161\/STROKEAHA.109.569855","article-title":"A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls","volume":"41","author":"Stevenson","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"10.1093\/advances\/nmaa080_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","article-title":"Aggregation of vascular risk factors and risk of incident Alzheimer disease","volume":"65","author":"Luchsinger","year":"2005","journal-title":"Neurology"},{"issue":"22","key":"10.1093\/advances\/nmaa080_bib8","first-page":"149","article-title":"Convergence of atherosclerosis and Alzheimer's disease: cholesterol, inflammation, and misfolded proteins","volume":"4","author":"Casserly","year":"2004","journal-title":"Discov Med"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/gerona\/glq026","article-title":"Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly: the InChianti study","volume":"65","author":"Zuliani","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"10.1093\/advances\/nmaa080_bib10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/hbm.24844","article-title":"Metabolic and vascular risk factors are associated with reduced cerebral blood flow and poorer midlife memory performance","volume":"41","author":"MacIntosh","year":"2020","journal-title":"Hum Brain Mapp"},{"key":"10.1093\/advances\/nmaa080_bib11","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina","year":"2016","journal-title":"Nat Commun"},{"key":"10.1093\/advances\/nmaa080_bib12","doi-asserted-by":"crossref","first-page":"635472","DOI":"10.1155\/2012\/635472","article-title":"Cardiovascular benefits of GLP-1-based therapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control","volume":"2012","author":"Forst","year":"2012","journal-title":"Exp Diabetes Res"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02048544","article-title":"Elevated triglyceride-rich lipoproteins in diabetes: a study of apolipoprotein B-48","volume":"33","author":"Curtin","year":"1996","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1463-1326.2012.01663.x","article-title":"GLP-1 receptor activated insulin secretion from pancreatic beta-cells: mechanism and glucose dependence","volume":"15","author":"Meloni","year":"2013","journal-title":"Diabetes Obes Metab"},{"issue":"1-2","key":"10.1093\/advances\/nmaa080_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mce.2008.08.012","article-title":"The incretin system and its role in type 2 diabetes mellitus","volume":"297","author":"Holst","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib16","doi-asserted-by":"crossref","first-page":"e003277","DOI":"10.1161\/JAHA.112.003277","article-title":"Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients","volume":"2","author":"Ayaori","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/CS20130708","article-title":"GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans","volume":"127","author":"Subaran","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"10.1093\/advances\/nmaa080_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/11635890-000000000-00000","article-title":"Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection","volume":"26","author":"Holscher","year":"2012","journal-title":"CNS Drugs"},{"issue":"9735","key":"10.1093\/advances\/nmaa080_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","article-title":"Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study","volume":"376","author":"O'Donnell","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1093\/advances\/nmaa080_bib20","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"issue":"4","key":"10.1093\/advances\/nmaa080_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","article-title":"Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review","volume":"8","author":"Feigin","year":"2009","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib22","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/S2214-109X(13)70089-5","article-title":"Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990\u20132010: findings from the Global Burden of Disease Study 2010","volume":"1","author":"Krishnamurthi","year":"2013","journal-title":"Lancet Glob Health"},{"issue":"10","key":"10.1093\/advances\/nmaa080_bib23","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1161\/STROKEAHA.113.001945","article-title":"Cerebral atherosclerosis is associated with cystic infarcts and microinfarcts but not Alzheimer pathologic changes","volume":"44","author":"Zheng","year":"2013","journal-title":"Stroke"},{"issue":"6801","key":"10.1093\/advances\/nmaa080_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"issue":"9913","key":"10.1093\/advances\/nmaa080_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","article-title":"Global and regional burden of stroke during 1990\u20132010: findings from the Global Burden of Disease Study 2010","volume":"383","author":"Feigin","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0038-1649503","article-title":"Global burden of stroke","volume":"38","author":"Katan","year":"2018","journal-title":"Semin Neurol"},{"issue":"8","key":"10.1093\/advances\/nmaa080_bib27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/WNL.58.8.1175","article-title":"The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function","volume":"58","author":"Posner","year":"2002","journal-title":"Neurology"},{"issue":"10","key":"10.1093\/advances\/nmaa080_bib28","doi-asserted-by":"crossref","first-page":"E382","DOI":"10.1503\/cmaj.161033","article-title":"Inflammation, cardiovascular disease and cancer: moving toward predictive medicine","volume":"189","author":"Ridker","year":"2017","journal-title":"CMAJ"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/cvr\/cvv188","article-title":"Fanning the flames: inflammation in cardiovascular diseases","volume":"107","author":"Libby","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1093\/advances\/nmaa080_bib30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1474-4422(05)70221-0","article-title":"Poststroke dementia","volume":"4","author":"Leys","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1093\/advances\/nmaa080_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000333412","article-title":"Post-stroke dementia and cognitive impairment","volume":"30","author":"Pasi","year":"2012","journal-title":"Front Neurol Neurosci"},{"issue":"Pt 12","key":"10.1093\/advances\/nmaa080_bib32","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1093\/brain\/awr273","article-title":"Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors","volume":"134","author":"Allan","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1212\/WNL.46.1.154","article-title":"Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960\u20131984)","volume":"46","author":"Kokmen","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib34","first-page":"351","article-title":"Cognitive impairment in lacunar strokes: the SPS3 trial","volume":"72","author":"Jacova","year":"2012","journal-title":"Neurol"},{"issue":"12","key":"10.1093\/advances\/nmaa080_bib35","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(07)70291-0","article-title":"Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study","volume":"6","author":"Seshadri","year":"2007","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbadis.2015.12.015","article-title":"Vascular cognitive impairment and dementia","volume":"1862","author":"Gorelick","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"3-4","key":"10.1093\/advances\/nmaa080_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000443614","article-title":"Cerebral small vessel disease and arterial stiffness: tsunami effect in the brain?","volume":"3","author":"Saji","year":"2016","journal-title":"Pulse"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr Opin Lipidol"},{"issue":"8","key":"10.1093\/advances\/nmaa080_bib39","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J Lipid Res"},{"issue":"5545","key":"10.1093\/advances\/nmaa080_bib40","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"10.1093\/advances\/nmaa080_bib41","doi-asserted-by":"crossref","unstructured":">41 Haines TH,. Do sterols reduce proton and sodium leaks through lipid bilayers? Prog Lipid Res. 2001;40(4):299\u2013324.","DOI":"10.1016\/S0163-7827(01)00009-1"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archneur.61.5.705","article-title":"Relation of plasma lipids to Alzheimer disease and vascular dementia","volume":"61","author":"Reitz","year":"2004","journal-title":"Arch Neurol"},{"issue":"6944","key":"10.1093\/advances\/nmaa080_bib43","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/bmj.308.6944.1604","article-title":"Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study","volume":"308","author":"Breteler","year":"1994","journal-title":"BMJ"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","article-title":"Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients","volume":"41","author":"Lutjohann","year":"2000","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1093\/advances\/nmaa080_bib45","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2003.11.009","article-title":"Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease","volume":"25","author":"Reiss","year":"2004","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0173(98)00008-3","article-title":"The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease","volume":"27","author":"Beffert","year":"1998","journal-title":"Brain Res Brain Res Rev"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","article-title":"The glia-neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D","volume":"26","author":"Liu","year":"2017","journal-title":"Cell Metab"},{"issue":"7","key":"10.1093\/advances\/nmaa080_bib48","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v66n0720","article-title":"A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease","volume":"66","author":"Papassotiropoulos","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1093\/advances\/nmaa080_bib49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00702-002-0809-1","article-title":"Brain region-dependent increases in beta-amyloid and apolipoprotein E levels in hypercholesterolemic rabbits","volume":"110","author":"Wu","year":"2003","journal-title":"J Neural Transm"},{"issue":"9","key":"10.1093\/advances\/nmaa080_bib50","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1532-5415.2004.52405.x","article-title":"Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study","volume":"52","author":"Riekse","year":"2004","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2009.10.043","article-title":"Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: the Three-City Study","volume":"210","author":"Bonaventure","year":"2010","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1093\/advances\/nmaa080_bib52","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1093\/advances\/nmaa080_bib53","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1749-6632.2000.tb06399.x","article-title":"Vascular involvement in cognitive decline and dementia: epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study","volume":"903","author":"Breteler","year":"2000","journal-title":"Annals NY Acad Sci"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2004.01.015","article-title":"Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus","volume":"16","author":"Mulder","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"11","key":"10.1093\/advances\/nmaa080_bib55","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.neurobiolaging.2005.09.011","article-title":"Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice","volume":"27","author":"Cao","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"3-4","key":"10.1093\/advances\/nmaa080_bib56","first-page":"174","article-title":"Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: a role for high-density lipoproteins?","volume":"28","author":"Mulder","year":"1998","journal-title":"Haemostasis"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib57","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.RES.72.5.1103","article-title":"High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation","volume":"72","author":"Matsuda","year":"1993","journal-title":"Circ Res"},{"issue":"11","key":"10.1093\/advances\/nmaa080_bib58","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1093\/advances\/nmaa080_bib59","doi-asserted-by":"crossref","first-page":"e50354","DOI":"10.1371\/journal.pone.0050354","article-title":"Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease","volume":"7","author":"Reitz","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib60","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/ern.09.25","article-title":"Cholesterol-modifying strategies for Alzheimer's disease","volume":"9","author":"Solomon","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib61","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/STROKEAHA.107.498535","article-title":"Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability Study","volume":"39","author":"Gouw","year":"2008","journal-title":"Stroke"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib62","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0021-9150(00)00601-8","article-title":"Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress","volume":"155","author":"Bae","year":"2001","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1093\/advances\/nmaa080_bib64","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/01.STR.0000221308.94473.14","article-title":"White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury","volume":"37","author":"Fernando","year":"2006","journal-title":"Stroke"},{"issue":"10","key":"10.1093\/advances\/nmaa080_bib65","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/33.10.3900195","article-title":"Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry","volume":"33","author":"Varndell","year":"1985","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0306-4522(96)00434-4","article-title":"Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem","volume":"77","author":"Larsen","year":"1997","journal-title":"Neuroscience"},{"issue":"4","key":"10.1093\/advances\/nmaa080_bib67","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"issue":"1-2","key":"10.1093\/advances\/nmaa080_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"J Mol Neurosci"},{"issue":"7","key":"10.1093\/advances\/nmaa080_bib69","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1523\/JNEUROSCI.23-07-02939.2003","article-title":"Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites","volume":"23","author":"Yamamoto","year":"2003","journal-title":"J Neurosci"},{"key":"10.1093\/advances\/nmaa080_bib70","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainres.2007.02.043","article-title":"Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei","volume":"1149","author":"Vrang","year":"2007","journal-title":"Brain Res"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib71","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1093\/advances\/nmaa080_bib72","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2012.09.071","article-title":"Preproglucagon (PPG) neurons innervate neurochemically identified autonomic neurons in the mouse brainstem","volume":"229","author":"Llewellyn-Smith","year":"2013","journal-title":"Neuroscience"},{"issue":"6","key":"10.1093\/advances\/nmaa080_bib73","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/db15-1141","article-title":"Glucagon-like peptide 1 receptor activation attenuates platelet aggregation and thrombosis","volume":"65","author":"Cameron-Vendrig","year":"2016","journal-title":"Diabetes"},{"issue":"6","key":"10.1093\/advances\/nmaa080_bib74","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1160\/TH16-07-0586","article-title":"Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation","volume":"117","author":"Barale","year":"2017","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1570161033476772","article-title":"Platelet activation, inflammatory mediators and hypercholesterolemia","volume":"1","author":"Ferroni","year":"2003","journal-title":"Curr Vasc PharmacolCVP"},{"issue":"6","key":"10.1093\/advances\/nmaa080_bib76","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dbi16-0014","article-title":"Glucagon-like peptide 1 receptor activation and platelet function: beyond glycemic control","volume":"65","author":"Jia","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-017-0646-z","article-title":"Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes","volume":"17","author":"Lambadiari","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib78","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.metabol.2012.09.004","article-title":"A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients","volume":"62","author":"Satoh-Asahara","year":"2013","journal-title":"Metabolism"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib79","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.112.195115","article-title":"Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism","volume":"60","author":"Liu","year":"2012","journal-title":"Hypertension"},{"key":"10.1093\/advances\/nmaa080_bib80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2840-9-17","article-title":"Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease","volume":"9","author":"Yamaoka-Tojo","year":"2010","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"10.1093\/advances\/nmaa080_bib81","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jacc.2014.11.043","article-title":"Decreased plasma levels of active glucagon-like peptide-1 in coronary artery disease","volume":"65","author":"Akiyama","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib82","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metab"},{"issue":"12","key":"10.1093\/advances\/nmaa080_bib83","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/14656566.2017.1342810","article-title":"GLP-1 receptor agonists, carotid atherosclerosis and retinopathy","volume":"18","author":"Rizzo","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2010.04.024","article-title":"One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress","volume":"212","author":"Bunck","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2010.05.028","article-title":"Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus","volume":"212","author":"Schwartz","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib86","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","article-title":"Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients","volume":"50","author":"Vilsboll","year":"2001","journal-title":"Diabetes"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib87","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00125-009-1611-5","article-title":"The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice","volume":"53","author":"Hsieh","year":"2010","journal-title":"Diabetologia"},{"issue":"4","key":"10.1093\/advances\/nmaa080_bib88","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/ene.13905","article-title":"Protection against stroke with glucagon-like peptide 1 receptor agonists: a systematic review and meta-analysis","volume":"26","author":"Barkas","year":"2019","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1093\/advances\/nmaa080_bib89","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/jcbfm.2011.51","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia","volume":"31","author":"Teramoto","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib90","doi-asserted-by":"crossref","first-page":"e97554","DOI":"10.1371\/journal.pone.0097554","article-title":"Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism","volume":"9","author":"Krasner","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/atv.0000615456.97862.30","article-title":"Endothelial GLP-1 (glucagon-like peptide-1) receptor mediates cardiovascular protection by liraglutide in mice with experimental arterial hypertension","volume":"40","author":"Helmstadter","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib92","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.112.091215","article-title":"A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity","volume":"127","author":"Noyan-Ashraf","year":"2013","journal-title":"Circulation"},{"issue":"Pt B","key":"10.1093\/advances\/nmaa080_bib93","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuropharm.2017.08.022","article-title":"Glucagon-like receptor 1 agonists and DPP-4 inhibitors: anti-diabetic drugs with anti-stroke potential","volume":"136","author":"Darsalia","year":"2018","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1093\/advances\/nmaa080_bib94","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.117.028136","article-title":"Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"136","author":"Nauck","year":"2017","journal-title":"Circulation"},{"issue":"10","key":"10.1093\/advances\/nmaa080_bib95","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00125-011-2241-2","article-title":"Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice","volume":"54","author":"Nagashima","year":"2011","journal-title":"Diabetologia"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib96","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1479164111404257","article-title":"A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-\/- mouse model","volume":"8","author":"Gaspari","year":"2011","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"10.1093\/advances\/nmaa080_bib97","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12974-019-1638-6","article-title":"The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke","volume":"16","author":"Shan","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1093\/advances\/nmaa080_bib98","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1167\/iovs.15-19006","article-title":"Protective effect of a GLP-1 analog on ischemia-reperfusion induced blood-retinal barrier breakdown and inflammation","volume":"57","author":"Goncalves","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1093\/advances\/nmaa080_bib99","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1093\/advances\/nmaa080_bib100","first-page":"CD006423","article-title":"Glucagon-like peptide analogues for type 2 diabetes mellitus","volume":"2011","author":"Shyangdan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/advances\/nmaa080_bib101","first-page":"407","article-title":"Twenty-four-week effects of liraglutide on body composition, adherence to appetite, and lipid profile in overweight and obese patients with type 2 diabetes mellitus","volume":"10","author":"Rondanelli","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib102","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.clinthera.2008.05.004","article-title":"Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study","volume":"30","author":"Schwartz","year":"2008","journal-title":"Clin Ther"},{"issue":"6","key":"10.1093\/advances\/nmaa080_bib103","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/ATVBAHA.112.246207","article-title":"Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans","volume":"32","author":"Xiao","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1093\/advances\/nmaa080_bib104","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00125-005-0126-y","article-title":"Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans","volume":"49","author":"Meier","year":"2006","journal-title":"Diabetologia"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib105","doi-asserted-by":"crossref","first-page":"G299","DOI":"10.1152\/ajpgi.90601.2008","article-title":"Stimulation of incretin secretion by dietary lipid: is it dose dependent?","volume":"297","author":"Yoder","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"18","key":"10.1093\/advances\/nmaa080_bib106","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1523\/JNEUROSCI.5977-08.2009","article-title":"Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity","volume":"29","author":"Nogueiras","year":"2009","journal-title":"J Neurosci"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib107","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2337\/db12-0202","article-title":"GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states","volume":"62","author":"Hein","year":"2013","journal-title":"Diabetes"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib108","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1871529X14666140505125300","article-title":"Glucagon-like peptide-1 as a key regulator of lipid and lipoprotein metabolism in fasting and postprandial states","volume":"14","author":"Farr","year":"2014","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"5","key":"10.1093\/advances\/nmaa080_bib109","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/ATVBAHA.114.304873","article-title":"Central nervous system regulation of intestinal lipoprotein metabolism by glucagon-like peptide-1 via a brain-gut axis","volume":"35","author":"Farr","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1093\/advances\/nmaa080_bib110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2016.11.001","article-title":"Intensive LDL-cholesterol lowering therapy and neurocognitive function","volume":"170","author":"Banach","year":"2017","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1093\/advances\/nmaa080_bib111","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresrev.2005.11.007","article-title":"Lipid metabolism in cognitive decline and dementia","volume":"51","author":"Panza","year":"2006","journal-title":"Brain Res Rev"}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216183132200357X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216183132200357X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/advances\/article-pdf\/11\/6\/1686\/34302376\/nmaa080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/advances\/article-pdf\/11\/6\/1686\/34302376\/nmaa080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:03:03Z","timestamp":1761872583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216183132200357X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S216183132200357X"],"URL":"https:\/\/doi.org\/10.1093\/advances\/nmaa080","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/advances\/nmaa080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by ELSEVIERCOMPANY on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}]}}